← Open Payments lookup

MICHELLE MARTIN: Open Payments

NPI 1316555667 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$476 in 12 payments from 6 companies in 2025. Trend: 2023 $99 · 2024 $179 · 2025 $476

Food & beverage: $476
CompanyPaymentsAmount
Gilead Sciences, Inc.1$147
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$108
Ipsen Biopharmaceuticals, Inc4$86
Madrigal Pharmaceuticals3$78
Mirum Pharmaceuticals, Inc.2$41
Novo Nordisk Inc1$15

Products named: XIFAXAN, IQIRVO, REZDIFFRA, Livmarli, Wegovy.

Industry payments across TX — which companies pay providers there.